12.50
-0.19 (-1.50%)
| Previous Close | 12.69 |
| Volume | 128,377 |
| Price / Earnings (Forward) | 138.89 |
| Price / Sales | 4.54 |
| Price / Book | 38.49 |
| 52 Weeks Range |
| Profit Margin | -29.42% |
| Operating Margin (TTM) | -22.85% |
| Diluted EPS (TTM) | -0.820 |
| Quarterly Revenue Growth (YOY) | 24.30% |
| Total Debt/Equity (MRQ) | 301.42% |
| Current Ratio (MRQ) | 6.63 |
| Operating Cash Flow (TTM) | -17.90 M |
| Levered Free Cash Flow (TTM) | -9.89 M |
| Return on Assets (TTM) | -11.52% |
| Return on Equity (TTM) | -128.49% |
AIStockmoo Score
| Value 38% | -2.5 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -2.5 |
| Timing 38% | -0.9 |
| AI Technical info | NA |
| Technical Oscillators info | -0.5 |
| Technical Moving Averages info | -1.5 |
| Sentiment 25% | 0.0 |
| Analyst Consensus info | 0.0 |
| News Mood info | NA |
| Smart Money | NA |
| Insider Activity info | NA |
| Institutional Flow info | NA |
| Short Interest info | NA |
| Environment | ×1.16 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | -5.7% |
| Pillar Agreement | ×1.25 |
| Not in score | |
| Price Volatility info | 4.3 |
| Final Score | -1.85 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Neuropace, Inc. | Mixed | Bullish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| NPCE | - | - | - | 38.49 |
| ZIMV | 535 M | - | - | 1.29 |
| ARAY | - | - | - | 0.170 |
| KIDS | - | - | - | 2.61 |
| BRKR | - | 0.32% | - | 4.10 |
| CLPT | - | - | - | 10.76 |
Select this tab to load the latest available analysis.
|
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 2.75% |
| % Held by Institutions | 86.29% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |